Compile Data Set for Download or QSAR
Report error Found 278 of ic50 for UniProtKB: P49761
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM130909(US8822500, Stauro- sporine | US9920060, Staurospor...)
Affinity DataIC50: 9.60nMAssay Description:Inhibition of human CLK3 using myelin basic protein as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627525(CHEMBL5441121)
Affinity DataIC50: 10nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639252(CHEMBL5560595)
Affinity DataIC50: 16nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627523(CHEMBL5438728)
Affinity DataIC50: 23nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627526(CHEMBL5439276)
Affinity DataIC50: 30nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627509(CHEMBL5430262)
Affinity DataIC50: 38nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50645374(CHEMBL5574295)
Affinity DataIC50: 39nMAssay Description:Inhibition of CLK3 (unknown origin) preincubated with enzyme for 10 mins followed by substrate and ATP addition measured after 60 mins by ADP-Glo rea...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50589392(Lorecivivint | Adavivint | Sm04690 | SM-04690 | SM...)
Affinity DataIC50: 44nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627439(CHEMBL5408907)
Affinity DataIC50: 49nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627440(CHEMBL5427842)
Affinity DataIC50: 53nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627446(CHEMBL5436754)
Affinity DataIC50: 73nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627490(CHEMBL5422486)
Affinity DataIC50: 90nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627420(CHEMBL5396550)
Affinity DataIC50: 96nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639249(CHEMBL5564232)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639248(CHEMBL5568383)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639245(CHEMBL5555969)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639242(CHEMBL5559924)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639255(CHEMBL5567834)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639254(CHEMBL5559906)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639253(CHEMBL5558849)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639259(CHEMBL5563432)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639258(CHEMBL5287080)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639256(CHEMBL5566340)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639265(CHEMBL5561941)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639264(CHEMBL5559654)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50639260(CHEMBL5565284)
Affinity DataIC50: 100nMAssay Description:Inhibition of CLK3 (unknown origin) incubated for 10 mins in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/11/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627575(CHEMBL5405233)
Affinity DataIC50: 107nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50592246(T3-CLK)
Affinity DataIC50: 110nMAssay Description:Inhibition of CLK3 (unknown origin) using ULight-CREBtide peptide as substrate incubated for 10 mins in presence of ATP incubated for 45 mins by LANC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627485(CHEMBL5400230)
Affinity DataIC50: 114nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627567(CHEMBL5413726)
Affinity DataIC50: 119nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627417(CHEMBL5396991)
Affinity DataIC50: 127nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627514(CHEMBL5439392)
Affinity DataIC50: 127nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627449(CHEMBL5428629)
Affinity DataIC50: 133nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627501(CHEMBL5430415)
Affinity DataIC50: 135nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627431(CHEMBL5439952)
Affinity DataIC50: 138nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627414(CHEMBL5412998)
Affinity DataIC50: 143nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627484(CHEMBL5417890)
Affinity DataIC50: 167nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627416(CHEMBL5427398)
Affinity DataIC50: 173nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627418(CHEMBL5411888)
Affinity DataIC50: 175nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627423(CHEMBL5417693)
Affinity DataIC50: 175nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627507(CHEMBL5429783)
Affinity DataIC50: 178nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627506(CHEMBL5404544)
Affinity DataIC50: 179nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627489(CHEMBL5438158)
Affinity DataIC50: 194nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627510(CHEMBL5428132)
Affinity DataIC50: 194nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627430(CHEMBL5414514)
Affinity DataIC50: 195nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627560(CHEMBL5407529)
Affinity DataIC50: 201nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627464(CHEMBL5426285)
Affinity DataIC50: 201nMAssay Description:Inhibition of human CLK3 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627552(CHEMBL5427325)
Affinity DataIC50: 201nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627428(CHEMBL5415622)
Affinity DataIC50: 205nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Center for Lymphoid Malignancies

Curated by ChEMBL
LigandPNGBDBM50627464(CHEMBL5426285)
Affinity DataIC50: 208nMAssay Description:Inhibition of human full length CLK3 (1 to 490 residues) expressed in Sf9 cells using S6 peptide and [gamma33P]ATP as substrate incubated for 60 mins...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
Displayed 1 to 50 (of 278 total ) | Next | Last >>
Jump to: